These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9789505)

  • 1. Cost of preventing HIV infection after sexual exposure.
    Lindbloom EJ; Stevermer JJ
    J Fam Pract; 1998 Oct; 47(4):251-2. PubMed ID: 9789505
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoprophylaxis after occupational exposure to human immunodeficiency virus in forensic autopsy.
    Kibayashi K; NG'walali PM; Tsunenari S
    Nihon Hoigaku Zasshi; 1998 Apr; 52(2):163-4. PubMed ID: 9711070
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prophylactic antiretroviral therapy after sexual exposure to HIV: 93 cases].
    Timsit FJ; Maillard A; Spindler E; Taquin Y; Deniaud F; Ferchal F; Morel P; Janier M
    Ann Dermatol Venereol; 2002; 129(6-7):866-9. PubMed ID: 12218913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early treatment of sexual exposure to human immunodeficiency virus].
    Derancourt C; Drobacheff C; Verraes S; Beguinot I; Bernard P
    Ann Dermatol Venereol; 2000 Jan; 127(1):122-4. PubMed ID: 10717578
    [No Abstract]   [Full Text] [Related]  

  • 6. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
    Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
    J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC considers 'morning after' therapy for sexual exposure. Centers for Disease Control and Prevention.
    AIDS Policy Law; 1997 Jun; 12(12):4. PubMed ID: 11364408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
    Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange J; Cooper DA; Phanuphak P
    Antivir Ther; 2006; 11(2):223-32. PubMed ID: 16640103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
    Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
    Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/AIDS following sexual assault in Jamaican children and adolescents: a case for HIV post-exposure prophylaxis.
    Steel-Duncan JC; Pierre R; Evans-Gilbert T; Rodriquez B; Christie CD
    West Indian Med J; 2004 Oct; 53(5):352-5. PubMed ID: 15675503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New recommendations on health care worker exposure to HIV.
    Woodward J
    STEP Perspect; 1996; 8(3):8-10. PubMed ID: 11364268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double protease inhibitor regimens with amprenavir show promise.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962
    [No Abstract]   [Full Text] [Related]  

  • 15. HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients.
    Quirino T; Niero F; Ricci E; Pusterla L; Carradori S; Gabbuti A; Iemoli E; Landonio S; Faggion I; Bonfanti P;
    Antivir Ther; 2000 Sep; 5(3):195-7. PubMed ID: 11075939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
    Jankelevich S; Mueller BU; Mackall CL; Smith S; Zwerski S; Wood LV; Zeichner SL; Serchuck L; Steinberg SM; Nelson RP; Sleasman JW; Nguyen BY; Pizzo PA; Yarchoan R
    J Infect Dis; 2001 Apr; 183(7):1116-20. PubMed ID: 11237839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
    Clark NM; Dieng Sarr A; Sankalé JL; Kanki PJ; Kazanjian P; Winfield R; Markovitz DM
    AIDS; 1998 Dec; 12(18):2506-7. PubMed ID: 9875594
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV postexposure prophylaxis after sexual assault: why is it so hard to accomplish?
    Cohen MS
    Sex Transm Dis; 2008 Dec; 35(12):979-80. PubMed ID: 18955917
    [No Abstract]   [Full Text] [Related]  

  • 19. Study shows three drugs better than two.
    AIDS Alert; 1997 Apr; 12(4):39. PubMed ID: 11364145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post-exposure prophylaxis in Zambia; the experiences of a tropical disease specialist following a cut accidentally incurred while operating on an HIV positive patient].
    Stekelenburg J
    Ned Tijdschr Geneeskd; 2002 Mar; 146(13):625-8. PubMed ID: 11957385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.